fbpx

QQQ
-4.48
382.79
-1.18%
BTC/USD
+ 926.29
48664.11
+ 1.94%
DIA
-2.49
350.67
-0.72%
SPY
-5.78
452.95
-1.29%
TLT
-0.72
150.61
-0.48%
GLD
-0.25
164.28
-0.15%

Curaleaf Makes Acquisition To Enter Ohio Cannabis Market

May 6, 2019 1:48 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Curaleaf Makes Acquisition To Enter Ohio Cannabis Market

Curaleaf Holdings Inc (OTC:CURLF)'s stock is trading higher Monday amid news the company plans to enter the Ohio cannabis market through the acquisition of Ohio Grown Therapies' cultivation and processing licenses.

What Happened

Curaleaf entered into a definitive agreement that grants it an option to buy Ohio Grown Therapies medical cannabis cultivation and processing licenses. The value of the deal is estimated at $20 million, including the lease of the company's facility.

Curaleaf said it can complete the acquisition of Ohio Grown Therapies' licenses and the lease in the second half of 2019. The full consideration will be paid upon completion of certain milestones.

Why It's Important

Ohio Grown Therapies is a medical cannabis company that has received a preliminary cultivation and processing licenses from the Ohio Department of Commerce. The company is working on building a 34,000 square foot facility in Johnstown, which includes 15,000 square feet for two-tier cultivation and 7,500 square feet for processing. Curaleaf is advising Ohio Grown Therapies on the building process.

Ohio legalized medical cannabis back in 2016, but first dispensaries only opened in January. Moreover, the state might legalize adult-use cannabis later this year, if the Marijuana Rights and Regulations Amendment will receive the greenlight from legislators to appear on the ballot on Nov. 5.

Ohio Grown Therapies represents the second acquisition announced by Curaleaf in less than a week. On May 1, the U.S. multi-state operator said it would buy the state-regulated cannabis business of Cura Partners, the owner of the Select cannabis wholesale brand in an all-stock deal worth nearly $950 million.

Curaleaf's stock traded around $11.25 per share Monday afternoon, up 4.5 percent.

Related Links:

Curaleaf Buys Cura Partners, Canopy Buys C3, Organigram Applies For Nasdaq Listing

TerrAscend Receives EU GMP Certification, Starts German Distribution

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Cannabis News M&A Markets

Related Articles

Cresco Labs Up By Nearly 3.5% - Here Are The Top Marijuana Stock Movers For Today

Cresco Labs Up By Nearly 3.5% - Here Are The Top Marijuana Stock Movers For Today

GAINERS: 22nd Century Group (NASDAQ:XXII) shares closed up 9.97% at $3.97 with an estimated market cap of $646,059,867. read more
Arena Pharma, GrowGen & HEXO Among Top Cannabis Stock Movers On August 23, 2021

Arena Pharma, GrowGen & HEXO Among Top Cannabis Stock Movers On August 23, 2021

GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 35.27% at $0.28 with an estimated market cap of $48,870,997. read more
Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?

Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?

As billionaires like Elon Musk, read more
The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More

The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More

Below is a recap of the main news related to the cannabis industry and markets for the week of August 13, 2021, which was marked by earnings reports out of many of the largest companies in the space – all details below. read more